FENOCOR 67MG TABLET
By Fenocor
Rx
20 Tablet in a Strip

Composition
Fenofibrate(67mg)

Manufacturer - Ordain Health Care Global Pvt Ltd
Exeltis - Ordain Health Care Global Pvt Ltd , Khivraj Complex - II, 4th Floor, No: 480, Anna Salai, Nandanam, Chennai - 600 035, Tamil Nadu, India.

Expires on or after
August, 2025

liver
It is important to note that FENOCOR 67MG TABLET is considered unsafe for use in individuals with liver disease and should be avoided. It is advised to consult your doctor before taking this medication. Additionally, the use of FENOCOR 67MG TABLET is not recommended for patients with severe liver disease.

kidney
When using FENOCOR 67MG TABLET, caution is advised for patients with kidney disease. Dosage may need adjustment, consult your doctor. Avoid in severe kidney disease.

alcohol
It is unsafe to drink alcohol while taking FENOCOR 67MG TABLET. Consult your doctor when consuming alcohol with FENOCOR 67MG TABLET.

driving
FENOCOR 67MG TABLET generally does not impact driving ability.

pregnancy
FENOCOR 67MG TABLET is considered unsafe during pregnancy based on limited human studies and harmful effects seen in animal studies. Your doctor will assess risks versus benefits before prescribing. Please consult your doctor before use.

breastfeeding
FENOCOR 67MG TABLET is considered unsafe during breastfeeding. Limited data indicates possible transfer of the drug to breastmilk and harm to the baby.
Habit Forming | No |
Chemical Class | PPAR alpha |
Therapeutic Class | - |
Action Class | PPAR alpha agonists (Fibrate) |
₹210.96
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 18-Nov-2024